Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092430
Status:
COMPLETED
Last Update Posted:
2019-11-15
First Post:
2004-09-22
Brief Title:
Study to Evaluate Frozen Versus Refrigerated MMRV Combined Measles Mumps Rubella and Varicella Investigational Vaccine V221-016
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Comparison of the Safety Tolerability and Immunogenicity of a Refrigerator-Stable Measles Mumps Rubella and Varicella Combination Vaccine V221 Refrigerated Versus V221 Frozen in Healthy Children
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to demonstrate that an investigational refrigerated vaccine with measles mumps rubella and varicella is well tolerated and has similar immune response when compared to a frozen vaccine with measles mumps rubella and varicella
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_076 | None | None | None |